Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Thoracic Neoplasms » Respiratory Tract Neoplasms » Lung Neoplasms » Bronchial Neoplasms » Carcinoma, Bronchogenic » Small Cell Lung Carcinoma
Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Neoplasms » Carcinoma, Bronchogenic » Small Cell Lung Carcinoma
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Neoplasms » Lung Neoplasms » Bronchial Neoplasms » Carcinoma, Bronchogenic » Small Cell Lung Carcinoma
Description
A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA). MeSH
Hierarchy View
Approved Indicated Drugs (6)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (59)
Phase 2 Indicated Drugs (174)
adenoviral vector expressing hsv-tk
autologous cytokine induced killer cells
autologous natural killer cells
Phase 1 Indicated Drugs (100)
allogeneic natural killer cells
anti-ny eso-1 tcr-transduced t cells
autologous dendritic cells loaded with autologous tumor lysate
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (90)
Cancer and Leukemia Group B (CALGB)
Case Western Reserve University
Danish Oncological Lung Cancer Group
Eastern Cooperative Oncology Group
EBMT Solid Tumors Working Party
European Lung Cancer Working Party
European Organisation for Research and Treatment of Cancer
Groupe Francais De Pneumo-Cancerologie
Intergroupe Francophone de Cancerologie Thoracique
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
National Cancer Institute (NCI)
North Central Cancer Treatment Group
People's Liberation Army of China
Schweizerische Arbeitsgruppe fuer angewandte Krebsforschung
Organization Involved with Phase 2 Indications (254)
Addario Lung Cancer Medical Institute
Advanced Accelerator Applications
Azienda Ospedaliera San Camillo Forlanini
Badalona Hospital Germans Trias i Pujol
Big Ten Cancer Research Consortium
Bureau of Science and Technology of Guangxi Province, China
Cancer Research and Biostatistics Clinical Trials Consortium
Cancer Treatment Centers of America
Cantonal Hospital of St. Gallen
Centre Georges Francois Leclerc
Chinese Academy of Medical Sciences
City of Hope National Medical Center
Clinica Universidad de Navarra
ECOG-ACRIN Cancer Research Group
European Thoracic Oncology Platform
First Hospital of Shijiazhuang City
First People's Hospital of Foshan
Groupe Hospitalier Paris Saint Joseph
Gruppo Oncologico Italiano di Ricerca Clinica
Guangzhou Panyu Central Hospital
Hellenic Cooperative Oncology Group
Hellenic Oncology Research Group
Hoosier Cancer Research Network
Hospital General Universitario Gregorio Marañon
Hospital General Universitario Morales Meseguer
Hospital Universitario Carlos Haya
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Innovent Biologics (Suzhou) Co. Ltd.
Institut de Cancerologie de l'Ouest Paul Papin
Institute of Oncology Dr. Rosell (IOR)
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Nazionale per lo Studio e la Cura dei Tumori
Istituto Oncologico Veneto IRCCS
James Graham Brown Cancer Center
Japan Multinational Trial Organization
Ludwig Institute for Cancer Research
Medical University of South Carolina
Moorgreen Hospital, Southampton
National Cheng Kung University
National Comprehensive Cancer Network
National Institutes of Health (NIH)
Norwegian University of Science and Technology
Philipps University of Marburg
Radiation Therapy Oncology Group
Royal Marsden Hospital NHS Trust
Sarcoma Oncology Research Center, LLC
Shijiazhuang Pharma Group (CSPC)
Simcere Pharmaceutical Co., Ltd
Southern Europe New Drug Organization (SENDO)
State University of New York, Buffalo
Translational Research in Oncology
University Hospital of North Norway
University Hospital Quirón Dexeus, Barcelona
University of Alabama, Birmingham
University of California, Los Angeles
University of California, San Francisco
University of Electronic Science and Technology of China
University of North Carolina at Chapel Hill
University of Texas at Houston
University of Western Brittany
Vestre Viken Ringerike Sykehus
Vita-Salute University of Milano. Italy
Organization Involved with Phase 1 Indications (56)
Askelios Klinik München Gauting
Central European Society for Anticancer Drug Research (CESAR)
Northwest Cancer Specialists, P.C.
Oncology Institute of Southern Switzerland
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
